A carregar...
Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors
Immune surveillance should be directed to suppress tumor development and progression, involving a balance of coinhibitory and costimulatory signals that amplify immune response without overwhelming the host. Immunotherapy confers durable clinical benefit in ‘immunogenic tumors’, whereas in other tum...
Na minha lista:
| Publicado no: | Immunotherapy |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5705793/ https://ncbi.nlm.nih.gov/pubmed/27197539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2016-0014 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|